Ashish Bhargava

43 papers and 712 indexed citations i.

Ashish Bhargava has authored 43 papers that have received a total of 712 indexed citations. This includes 21 papers in Infectious Diseases, 13 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. The topics of these papers are COVID-19 Clinical Research Studies (13 papers), Antibiotic Use and Resistance (7 papers) and Long-Term Effects of COVID-19 (7 papers). Ashish Bhargava is often cited by papers focused on COVID-19 Clinical Research Studies (13 papers), Antibiotic Use and Resistance (7 papers) and Long-Term Effects of COVID-19 (7 papers) and collaborates with scholars based in United States, Nepal and India. Ashish Bhargava's co-authors include Teena Chopra, Keith S. Kaye, Dror Marchaim, Kayoko Hayakawa and Paul Lephart and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy